Source: Annual Congress 2012 - New biomarkers for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
B. Bartling, H.S. Hofmann, A. Sohst, V. Somoza, R.E. Silber, A. Simm (Halle (Saale), Regensburg, Germany; Vienna, Austria). Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma. Eur Respir J 2012; 40: Suppl. 56, 4208

Member's Comments

No comment yet.

Related content which might interest you: Measures of lung function and their relationship with advanced glycation end-products Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019 Year: 2020 Plasma advanced glycation end-products and skin autofluorescence are increased in COPD Source: Eur Respir J 2014; 43: 430-438 Year: 2013 Reduced soluble receptor for advanced glycation end-products in COPD Source: Eur Respir J 2011; 37: 516-522 Year: 2011 Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Importance of the receptor for advanced glycation end products in the respiratory mechanics Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018 Year: 2019 Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Soluble RAGE is deficient in neutrophilic asthma and COPD Source: Eur Respir J 2012; 39: 721-729 Year: 2012 Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Treatment of non-microcelular lung cancer in its advanced stage Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016 Anticancer treatment for advanced non-small cell lung cancer Source: Breathe 2011; 8: 124-133 Year: 2011 Management of locally advanced nonsmall cell lung cancer Source: Eur Respir Mon; 2009: 44: 260–270 Year: 2009 Assessment of lipid peroxidation and antioxidant capacity in pulmonary parenchyma and lung cancer tissue in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 Advanced non-small cell lung cancer in elderly patients Source: Breathe 2012; 9: 26-34 Year: 2012